Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $81.42 million. The enterprise value is $105.55 million.
| Market Cap | 81.42M |
| Enterprise Value | 105.55M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, before market open.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 130.27 million shares outstanding. The number of shares has increased by 19.57% in one year.
| Shares Outstanding | 130.27M |
| Shares Change (YoY) | +19.57% |
| Shares Change (QoQ) | -4.04% |
| Owned by Insiders (%) | 7.34% |
| Owned by Institutions (%) | 69.42% |
| Float | 40.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| Forward PS | 0.66 |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | 29.30 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.34 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 7.98 |
| Debt / FCF | n/a |
| Interest Coverage | -0.03 |
Financial Efficiency
Return on equity (ROE) is -3.60% and return on invested capital (ROIC) is -15.77%.
| Return on Equity (ROE) | -3.60% |
| Return on Assets (ROA) | -1.90% |
| Return on Capital (ROIC) | -15.77% |
| Revenue Per Employee | $489,043 |
| Profits Per Employee | -$8,029 |
| Employee Count | 207 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | -1.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.88% in the last 52 weeks. The beta is 0.33, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -19.88% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 36.57 |
| Average Volume (20 Days) | 78,016 |
Short Selling Information
The latest short interest is 208,852, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 208,852 |
| Short Previous Month | 226,801 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.52% |
| Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, XTNT had revenue of $101.23 million and -$1.66 million in losses. Loss per share was -$0.01.
| Revenue | 101.23M |
| Gross Profit | 62.23M |
| Operating Income | -12.05M |
| Pretax Income | -3.30M |
| Net Income | -1.66M |
| EBITDA | 3.60M |
| EBIT | -105,000 |
| Loss Per Share | -$0.01 |
Balance Sheet
The company has $4.62 million in cash and $28.76 million in debt, giving a net cash position of -$24.13 million or -$0.19 per share.
| Cash & Cash Equivalents | 4.62M |
| Total Debt | 28.76M |
| Net Cash | -24.13M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | 47.68M |
| Book Value Per Share | 0.37 |
| Working Capital | 38.10M |
Cash Flow
In the last 12 months, operating cash flow was -$13.03 million and capital expenditures -$1.53 million, giving a free cash flow of -$14.56 million.
| Operating Cash Flow | -13.03M |
| Capital Expenditures | -1.53M |
| Free Cash Flow | -14.56M |
| FCF Per Share | -$0.11 |
Margins
Gross margin is 61.47%, with operating and profit margins of -11.91% and -1.64%.
| Gross Margin | 61.47% |
| Operating Margin | -11.91% |
| Pretax Margin | -3.26% |
| Profit Margin | -1.64% |
| EBITDA Margin | 3.56% |
| EBIT Margin | -0.10% |
| FCF Margin | -14.38% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.57% |
| Shareholder Yield | -19.57% |
| Earnings Yield | -2.04% |
| FCF Yield | -17.88% |
Analyst Forecast
The average price target for XTNT is $2.10, which is 236.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.10 |
| Price Target Difference | 236.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -1.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.07 |
| Piotroski F-Score | 3 |